Global law firm White & Case LLP has advised Kedrion S.p.A. on the issuance of its €410 million 3.375% senior secured notes due 2026, issued pursuant to Rule 144A and Regulation S under the Securities Act, and on its new €240 million multi-currency term and revolving credit facilities.
Proceeds from the issuance of the notes will refinance part of Kedrion’s bank indebtedness and fund a partial tender offer to repurchase €150 million of its existing senior notes due 2022.
Kedrion is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating serious diseases, disorders and conditions such as hemophilia and immune system deficiencies.
White & Case advised on the US, English and Italian law aspects of the transaction with a deal team led by partners Michael Immordino (London & Milan), Iacopo Canino (Milan) and James Greene (London), and including partners Gregory Owens (New York) and Chad McCormick (Houston), associates Robert Becker, Bianca Caruso, Pietro Magnaghi (all Milan), Andrew Bayer and Kyle Ezzedine (both New York), and lawyers Luca Misseroni and Emma Lo Re (both Milan).
For more information please speak to your local media contact.